Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
The bill requires the Comptroller General (GAO) to report to Congress within one year on esophageal cancer in the Federal Employees Health Benefits (FEHB) Program. The report must evaluate FEHB spending for enrollees diagnosed with esophageal cancer and assess how often FEHB enrollees identified as high-risk receive guideline-recommended screening.
Liberals emphasize screening access, equity, and translating findings into coverage
Relative to its intended legislative type, this bill is a straightforward, well-scoped reporting requirement directing the Comptroller General to evaluate FEHB spending and screening frequency for esophageal cancer risk within a 1-year timeframe.
The bill requires the Comptroller General (GAO) to report to Congress within one year on esophageal cancer in the Federal Employees Health Benefits (FEHB) Program.
The report must evaluate FEHB spending for enrollees diagnosed with esophageal cancer and assess how often FEHB enrollees identified as high-risk receive guideline-recommended screening.
Simple, narrow reporting requirement on a noncontroversial health topic with minimal fiscal impact increases prospects, though many stand‑alone bills still stall.
Relative to its intended legislative type, this bill is a straightforward, well-scoped reporting requirement directing the Comptroller General to evaluate FEHB spending and screening frequency for esophageal cancer risk within a 1-year timeframe.
Liberals emphasize screening access, equity, and translating findings into coverage
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize screening access, equity, and translating findings into coverage
Likely supportive because the bill targets early detection, prevention, and federal oversight of health spending.
It could identify gaps in screening access and prompt policies to reduce disparities and improve outcomes for esophageal cancer.
Generally favorable as a low-cost informational step that improves oversight of federal health benefits.
Will look for rigorous methodology, clear cost estimates, and practical recommendations before endorsing policy changes.
Likely cautiously supportive because the bill only requests a report rather than new regulation or spending mandates.
Some concern may remain about potential downstream recommendations that expand federal involvement or increase FEHB costs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Simple, narrow reporting requirement on a noncontroversial health topic with minimal fiscal impact increases prospects, though many stand‑alone bills still stall.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize screening access, equity, and translating findings into coverage
Simple, narrow reporting requirement on a noncontroversial health topic with minimal fiscal impact increases prospects, though many stand‑a…
Relative to its intended legislative type, this bill is a straightforward, well-scoped reporting requirement directing the Comptroller General to evaluate FEHB spending and screening frequency for esophageal cancer risk…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.